Table 1 Clinical areas covered by the flagships in the Melbourne Genomics Alliance program, in infants, children and adults

The five clinical areas included in the Demonstration Project phase were:

 Hereditary neuropathies, conditions of the peripheral nervous system

 Focal epilepsy

 Hereditary colorectal cancer

 Genetic conditions of childhood, in infants and children (Childhood Syndromes)

 Bone marrow transplants in acute myeloid leukaemia (AML)

The six clinical areas of the Flagships in phase one of Horizon One, during the period 2016 to 2018:

 Immunology

 Dilated cardiomyopathy

 Congenital deafness

 Complex care in children

 Advanced non-Hodgkin lymphoma

 Advanced solid cancers

The five areas of the Flagships for phase two of Horizon One, during the period 2017 to 2019:

 Bone marrow failure

 Controlling superbugs – resistant microorganisms

 Complex neurological and neurodegenerative diseases

 Genetic kidney disease

 Perinatal autopsy

And ‘Additional findings’ project